Grant of Options

RNS Number : 6071Y

Futura Medical PLC

10 September 2015

 



For immediate release

10 September 2015

Futura Medical plc

("Futura" or the "Company")

Grant of Options

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 9 September 2015 it granted options over a total of 400,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.

Director	Number of options granted	Exercise price	Exercise period	Total number of options held following notification	Total number of ordinary shares held
J H Barder	250,000	30.0p	1 Oct 2017 - 30 Sep 2022	1,500,000	1,008,830
D A Martin	150,000	30.0p	1 Oct 2017 - 30 Sep 2022	869,279	280,000

The new options were granted under the Futura Medical plc Unapproved Share Option Scheme.

The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.

For further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
Email to: [e-mail]	www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong / Tom Smale - Corporate Finance	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSLLFIDAEIAIIE